Ticker Details
Johnson & Johnson Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$558.86B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.83 | 0.75%
Avg Daily Range (30 D):	$2.22 | 0.97%
Avg Daily Range (90 D):	$2.12 | 0.90%

Institutional Daily Volume
Avg Daily Volume:	7.88M
Avg Daily Volume (30 D):	5.05M
Avg Daily Volume (90 D):	5.69M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	35
Avg Trade Size (Sh.) (90 D):	36

Institutional Trades
Total Institutional Trades:	161,841
Avg Institutional Trade:	$8.68M
Avg Institutional Trade (30 D):	$38.4M
Avg Institutional Trade (90 D):	$35.71M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	28

Market Closing Trades
Avg Closing Trade:	$126.1M
Avg Closing Trade (30 D):	$352.13M
Avg Closing Trade (90 D):	$374.43M
Avg Closing Volume:	946.82K

News

Jun 3, 2026 @ 4:05 PM 1 Sector Warren Buffett and Greg Abel Are Largely ... Source: Adria Cimino

Jun 3, 2026 @ 4:09 AM Johnson & Johnson late-breaking results show nipoc... Source: Johnson & Johnson

Jun 2, 2026 @ 11:10 AM State Street's Health Care ETF Tops Invesco's on Y... Source: Sarah Sidlow

Jun 1, 2026 @ 3:19 PM 3 Dividend Kings That Earn Their Crown Every Quart... Source: Chris Markoch

May 31, 2026 @ 12:39 PM Johnson & Johnson's Phase 3 prostate cancer study ... Source: Johnson & Johnson

Financials
	TTM	Q4 2026	Q4 2025
Basic EPS	$8.73	$2.17	$2.12
Diluted EPS	$8.64	$2.14	$2.09
Revenue	$96.36B	$24.06B	$24.56B
Gross Profit	$65.36B	$15.96B	$16.6B
Net Income / Loss	$21.04B	$5.24B	$5.12B
Operating Income / Loss	$24.94B	$5.99B	$4.97B
Cost of Revenue	$31.01B	$8.11B	$7.97B
Net Cash Flow	$-16786M	$1.98B	$1.48B
PE Ratio

Splits
Jun 13, 2001	2:1